Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02156804 |
|---|---|
| Brief Title: | A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172) |
| First Submitted : | May 29, 2014 |
| First Submitted that Met QC Criteria : | June 2, 2014 |
| First Posted : | June 5, 2014 (Estimate) |
| Results First Submitted : | January 10, 2020 |
| Results First Submitted that Met QC Criteria : | February 10, 2020 |
| Results First Posted : | February 20, 2020 |
| Last Update Submitted that Met QC Criteria : | September 9, 2020 |
| Last Update Posted : | September 11, 2020 |